Clinical efficacy of cefaclor and cefradine in treatment of respiratory tract infections

Objective To investigate the clinical efficacy of cefaclor and cefradine in treatment of respiratory tract infections. Methods From January to June 2013 in our hospital, 98 patients with respiratory tract infections were analyzed, according to the treatment they were divided into observation group and control group with 49 cases each group, the observation group used cefaclor treatment while the control group used cefradine treatment, to observe clinical efficacy, bacterial sensitivity bacterial clearance rate, body temperature, white blood cell count, and respiratory rate changes before and after treatment and the occurrence of adverse reactions. Results The total effective rate, bacterial sensitivity and bacterial clearance rate of observation group were significantly higher than control group(P 0.05); After treatment, body temperature, white blood cell counts were significantly lower(P 0.05), respiratory rate had improved significantly(P 0.05), and the observation group improved significantly better than the control group(P 0.05); There were no serious adverse events. Conclusion Cefaclor treatment of respiratory tract infections is better than cefradine, worthy of promotion.